Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Devine

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|July 19, 2005
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF aloneS M Devine, R A Brown, V Mathews, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Human Gene Therapy|August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivoA Bartholomew, S Patil, A Mackay, et al.
Bone Marrow Transplantation|July 29, 2014
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myelomaS M Jaglowski, A S Ruppert, C C Hofmeister, et al.
Bone Marrow Transplantation|October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantS M Devine, R Sanborn, E Jessop, et al.
Bone Marrow Transplantation|April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphomaJ B Cohen, N C Hall, A S Ruppert, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|July 19, 2005
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF aloneS M Devine, R A Brown, V Mathews, et al.
Bone Marrow Transplantation|July 1, 1997
Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipientsJ R Wingard, R A Nash, V Ratanatharathorn, et al.
Transplantation Proceedings|February 1, 1995
FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantationJ W Fay, R A Nash, J R Wingard, et al.
Human Gene Therapy|August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivoA Bartholomew, S Patil, A Mackay, et al.
Bone Marrow Transplantation|July 29, 2014
The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myelomaS M Jaglowski, A S Ruppert, C C Hofmeister, et al.
Bone Marrow Transplantation|October 19, 2001
Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantS M Devine, R Sanborn, E Jessop, et al.
Bone Marrow Transplantation|April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphomaJ B Cohen, N C Hall, A S Ruppert, et al.
Experimental Hematology|February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusionS M Devine, A M Bartholomew, N Mahmud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive careH K Holland, S P Dix, R B Geller, et al.
Leukemia|September 27, 2013
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myelomaJ Chu, Y Deng, D M Benson, et al.
Pageof 5